References
- Huang CH, Johe KK, Seifter S, Blumenfeld OO. Biochemistry and molecular biology of MNSs blood group antigens. Bailliere’s Clinical Haematology 1991;4:821–48.
- Huang CH, Blumenfeld OO. Molecular genetics of human erythrocyte MiIII and MiVI glycophorins. Use of pseudoexon in construction of two delta-alpha-delta hybrid genes resulting in antigenic diversification. J Biol Chem 1991;266:7238–55.
- Dahr W. Miltenberger subsystem of the MNSs blood group system, review and outlook. Vox Sang 1992;62:129–35.
- Cleghorn TE. The occurrence of certain rare blood group factors in Britain, 1961. M.D. thesis, University of Sheffield.
- Chandanayingyong D, Pejrachandra S. Studies on the Miltenberger complex frequency in Thailand and family studies. Vox Sang 1975b;28:152–5.
- Broadberry RE, Lin M. The incidence and significance of anti-“Mia” in Taiwan. Transfusion 1994;34:349–52.
- Poole J, King MJ, Mak KH, Liew YW, Leong S, Chua KM. The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies. Transfus Med 1991;1:169–75.
- Issitt PD. Applied blood group serology. 3rd ed. Miami, FL: Montgomery Scientific Publications, 1985:350–1.
- Race RR, Sanger R. Blood groups in man. 6th ed. Oxford: Blackwell Scientific Publications, 1975:126.
- Taylor AM, Knighton GJ. A case of severe hemolytic disease of the newborn due to anti-Verweyst. Transfusion 1982:165–6.
- Lin M, Broadberry RE. An intravascular hemolytic transfusion reaction due to anti-“Mia” in Taiwan. Vox Sang 1994;67:320.
- Cheng G, Hui CH, Lam CK, et al. Haemolytic transfusion reactions due to Mi antibodies; need to include MiIII positive cells in pre-transfusion antibody screening in Hong Kong. Clin Lab Haem 1995;17:183–4.
- Walker RH, editor-in-chief. Technical manual. 11th ed. Bethesda, MD: American Association of Blood Banks, 1993.
- Olson PR, Weiblen BJ, O’Leary JJ, Moscowitz AJ, McCullough J. A simple technique for the inactivation of IgM antibodies using dithiothreitol. Vox Sang 1976;30:149–59.
- Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352–3.
- King MJ, Poole J, Anstee DJ. An application of immunoblotting in the classification of the Miltenberger series of blood group antigens. Transfusion 1989;29:106–12.
- Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.
- Schanfield MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically significant antibodies in the laboratory. In: Sandler SG, Nusbacher J, Schanfield MS, eds. Immunobiology of erythrocytes. New York, NY: Alan R Liss, 1980:305–23.
- Hadley AG, Poole GD, Fraser ID. Predicting the severity of haemolytic disease of the newborn: prospective evaluation of the chemiluminescence test (letter). Vox Sang 1992;63:291–2.
- Lin CK, Mak KH, Szeto SC, et al. First case of hemolytic disease of the newborn due to anti-Mur in Hong Kong (in press, Clin Lab Haematol).
- Feng CS. The clinical significance of anti-“Mia” (letter). Transfusion 1994;11:1014.